The combination of brain imaging and genetics promises to identify neural mechanisms underlying complex traits such as cognition and psychiatric disorder. The study by Heck et al. (2014) in this issue of Neuron highlights voltage-gated cation channel activity as a likely link and culprit.
Disorders such as schizophrenia and mood disorders account for more than 15% of all days lived with disability but have so far been slow to reveal their underlying neural mechanisms. Cognitive decline-most often first seen as loss of short-term, or working, memory-is a common fear in aging, presaging dementia. Patients with schizophrenia consistently show significant deficits in working memory, as to a lesser extent do patients with bipolar disorder. How might mechanisms underlying psychiatric conditions such as schizophrenia be related to the universal trait of cognition? We know that both have a substantial genetic component. At the most recent count, some 20% of the genetic variance in schizophrenia has been ascribed to around 100 genes, each contributing a very small incremental increase to risk (Ripke et al., 2013) . There is evidence for a significant polygenic component (aggregate impact of many genetic variants each of small effect) and for genetic overlap between schizophrenia and bipolar disorder (Purcell et al., 2009 ). Both of these disorders have a cognitive component. There is likewise evidence for a significant polygenic component to cognition in the normal population (Davies et al., 2011) and to cognitive change over the life course (Deary et al., 2012) . Moreover, there is evidence for shared genetic architecture between schizophrenia and general cognitive ability (McIntosh et al., 2013) . But which genes matter most? To date, APOE is the best, but perhaps only, example of a candidate gene that is reliably and consistently associated with cognitive functions, explaining 2% of the variance (Wisdom et al., 2011) . Other candidate genes almost always fail to replicate (Payton, 2009; Chabris et al., 2012) , most likely because this well-measured trait is the compound of many different gene functions, each of small effect, and with no two individuals inheriting quite the same set. The chance of any one variant rising to the top in a genetic association study will be slight. Herein lies the (at least) 2-fold problem for cognition, true also for many other complex traits, namely of phenotypic heterogeneity and of specificity generality-how direct (causal) is the trait association and how specific is it to the trait measured? Both problems are relevant to the report by Heck et al. (2014) in the current edition of Neuron.
The n-back task (Gevins and Cutillo, 1993) is the gold standard brain-imaging task to assess working memory. It is a test of ordered memory recall of letter sequences; the 0-back task sets the baseline and the 2-back tests the ability to recall the letter that was 2 steps back in the order presented. Using the 2-back test of working memory as a quantitative trait, Heck et al. (2014) took an agnostic view and surveyed the whole genome for common SNPs that were significantly associated with a deficit in working memory, as defined by the 2-back test. They found five such SNPs, four clustered on chromosome 12, spanning PAWR, a brain-expressed transcriptional regulator, and one on chromosome 1, within an intron of OLFM3, encoding olfactomedin.
That may seem like poor pickings from an analysis of a reassuringly large discovery set of 905 healthy participants but was really a side show, not developed further, to the real substance of the study.
Standard practice would be to repeat the analysis directly in one or more cohort with equivalent measures. They do report evidence for replication, in two independent cohorts, but by a relatively novel approach and with caveats to which we will return later. First, they took the GWAS data from the discovery set of 905 individuals and transformed the data into a gene set enrichment analysis. Here, rather than just look at those few individual SNPs that pass an agreed threshold for genome-wide significance, the idea is to take a more inclusive approach from a more functional perspective. In gene set enrichment, you first assign each SNP to the most proximal gene in the genome, take the most significant associations, and sort the genes by functional annotation. Now you can ask, do any ontologies rise to the surface as significantly associated with working memory? The answer was yes. Two out of the comprehensive set of 1,411 tested exceeded the false discovery test of significant association. These were ''voltage-gated cation channel activity'' (GO:0022843) and ''transport of glucose and other sugars, bile salts and organics acids, metal ions and amine compounds'' (Reactome). Given the objective of the study, you have to like the look of the first class, because these channels are known to regulate neuronal excitability, but what can you make of the second? This is both the blessing and the curse of the general approach-gene ontologies reflect the state of knowledge about gene function, which is both limited and biased by virtue of the foregoing research. Even those that survive the false discovery tests will inevitably include false positives. Independent replication is essential.
Inspection of GWAS data in two other well-sized cohorts (n = 746 and n = 410) with brain imaging and proxies for measures of working memory found supporting genetic evidence for the ''voltage-gated cation channel activity'' gene set, but not the ''reactome,'' so that was encouraging. It is important to acknowledge that there is some controversy around genome enrichment analysis software-which works best and how robust are the outputs-but the ''voltage-gated cation channel activity'' finding did replicate across multiple software platforms.
However, there is a bigger caveat that poses a wider and provocative question: the replication sets did not have identical cognitive measures. The Zurich sample of younger adults took the Wechsler forward digit span task, and the AgeCoDe sample of cognitively healthy elder subjects took a word list learning task. Neither of these tasks would normally be viewed as a test of working memory: backward digit span or letter-number sequencing are those Wechsler tasks that are sometimes called working memory, and word list learning is typically thought of as verbal declarative memory. In any case, these tests have modest phenotypic correlations with the n-back task. This cuts two ways for Heck et al. (2014) . If there were failure to replicate from the n-back studies to Zurich and AgeCoDe, then one might simply appeal to phenotypic heterogeneity. In other words, the so-called attempt at replication was, in fact, addressing a different phenotype. However, to the extent that there is some replication to Zurich and AgeCoDe forces us to consider whether the results tell us something more about cognition than just working memory. It is well established that variation in cognitive tests comes from at least three sources: general cognitive ability, domain-specific cognitive ability, and task-specific cognitive ability (Deary et al., 2010) . Thus, when a person performs well in, say, the n-back task, this might be because they are good at all cognitive tests, and/or good at memory tests in general, and/or especially good at the n-back task. And we must add to this that working memory tasks are quite strongly loaded on general cognitive ability and that working memory and general cognitive ability have a strong genetic correlation (Goldberg et al., 2013) . Therefore, before we conclude that Heck et al. (2014) have only told us something specific about working memory, we should test whether they have, in fact, told us something about memory in general or about general cognitive ability variation.
The link between working memory and voltage-gated cation channel activity is not only biologically plausible, it is also consistent with their own and other recent findings from psychiatric genetics. They report a robust replication for the association in a publicly available GWAS data set from the Psychiatric Genetics Consortium's analysis of schizophrenia in a large Swedish case-control study (Ripke et al., 2013 ). This should not perhaps come as too great a surprise as one prominent member of this gene set is CACNA1C, known to harbor variants that confer risk to schizophrenia (Ripke et al., 2013) . Adding further weight to the finding, the Psychiatric Genetics Consortium recently reported an increased burden of rare coding variants in this gene set (Purcell et al., 2014) . Heck et al. (2014) further show that the ''voltage-gated cation channel activity'' gene set regulates cortical activity during a working (but not episodic) memory fMRI paradigm. The imaging sample was selected from individuals within the replication sample, rather than being selected completely independently of the other findings, so that warrants further work. What is also currently lacking is a clear link from gene set enrichment through brain activity to working memory task performance outside of the scanner. This could be remedied in future studies by employing measures where the withinscanner task-associated activations and ''real-life'' performance are more highly correlated.
To conclude, this study substantially raises the bar for future functional imaging studies of genetic variants. It is rigorous in its methodology and sample size. The relevance to schizophrenia has been highlighted and the value of fMRI studies that might tease out the brain circuitry is signaled if not yet fully developed. Combining state-of-the-art functional brain imaging with large study samples and genomic analysis is however very challenging. While this effort is important for our mechanistic understanding of brain function, cognition, and mental illness, such well-founded samples sets are few and far between. Efforts to combine and standardize large imaging samples are underway (such as ENIGMA [Thompson et al., 2014] and the Human Connectome project [Van Essen et al., 2013] ). The UK Biobank has initiated pilot body and brain imaging studies, which if successful will extend to as many as 100,000 of this 500,000 strong cross-sectional casecontrol cohort (http://www.ukbiobank. ac.uk/2013/09/uk-biobank-welcomesimaging-funding/). These consortia will focus on structural and connectivity measures that can be generalized across multiple centers to better describe the human brain ''connectome.'' These efforts promise to bring the same ''big data'' approaches, openness, and methodological rigor to imaging science that has led to step changes in progress to detect and define genome associations with disease and disease-related traits through the formation of international consortia. In this regard, the study by Heck et al. (2014) is a real step forward in brain imaging genomics.
Motor neurons in ALS die via cell-autonomous and non-cell-autonomous mechanisms. Using adult human astrocytes and motor neurons, Re et al. (2014) , in this issue of Neuron, discover that familial and sporadic ALS-derived human adult astrocytes secrete neurotoxic factors that selectively kill motor neurons through necroptosis, suggesting a new therapeutic avenue.
Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease, is an adult-onset neurodegenerative disease manifested by degeneration of motor neurons in motor cortex, brain stem, and spinal cord, resulting in muscle paralysis and ultimately death (Rowland and Shneider, 2001) . While the disease is dominantly inherited in approximately 10% of patients (termed familial), most often the disease is sporadic, with largely unknown genetic etiology. Numerous hypotheses have been proposed to account for the diseaseassociated motor neuron loss, including conformational instability of proteins triggering neurotoxicity, perturbations of RNA processing, mitochondrial dysfunction, defective axonal transport, excitotoxicity, and inflammation (reviewed in (Rothstein, 2009 ). However, the precise molecular mechanism(s) that target motor neurons for death and result in the pathological manifestations still remain elusive. Studies reporting mutations in the SOD1 gene encoding the antioxidant enzyme Cu/Zn superoxide dismutase-1 provided the first genetic link to ALS (Rosen et al., 1993) . Since then, studies have implicated both cell-autonomous and non-cell-autonomous mechanisms in SOD1-mediated toxicity (Clement et al., 2003) . The identity of such cell types that modulate motor neuron survival came from studies using cultured motor neurons derived from embryonic spinal cord or differentiated from embryonic stem cells (Di Giorgio et al., 2008; Marchetto et al., 2008; Nagai et al., 2007) . In these studies, cocultured motor neurons were less likely to survive when they were on astrocytes that express mutant SOD1. Exposure of cultured motor neurons to conditioned media derived from astrocytes also affected survival of motor neurons, probably through soluble factors released by mutant SOD1-expressing astrocytes. In coculture systems with motor neurons, astrocytes derived from sporadic ALS (sALS) postmortem spinal cord neural progenitor cells (NPCs) also selectively killed motor neurons (Haidet-Phillips et al., 2011) , suggesting a shared astrocyte-dependent disease mechanism between familial and sporadic forms of ALS. While these studies point to astrocytes as
